University of Southern California Listed a New Clinical Trial for Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease

Press/Media

Period	21 Nov 2022

Media coverage

Title	University of Southern California Listed a New Clinical Trial for Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
Media name/outlet	India Pharma News
Country/Territory	India
Date	21/11/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66XG-X0G1-DXMP-K4J3-00000-00
Persons	Brian Lee, Brian Lee